1203-96-9 Usage
Uses
Used in Pharmaceutical Research and Development:
5-METHYL-1H-INDAZOLE-3-CARBOXYLIC ACID HYDRAZIDE is used as a key intermediate in the synthesis of biologically active compounds for pharmaceutical applications. Its unique structure and reactivity contribute to the development of new drugs with potential therapeutic benefits.
Used in Organic Synthesis:
In the field of organic synthesis, 5-METHYL-1H-INDAZOLE-3-CARBOXYLIC ACID HYDRAZIDE serves as a valuable building block for the creation of complex organic molecules. Its versatility in chemical reactions allows for the synthesis of a wide range of compounds with diverse applications.
Used in Chemical and Biological Process Studies:
Due to its unique structure and reactivity, 5-METHYL-1H-INDAZOLE-3-CARBOXYLIC ACID HYDRAZIDE is utilized in the study of various chemical and biological processes. This helps researchers gain insights into the fundamental aspects of these processes and potentially discover new applications for 5-METHYL-1H-INDAZOLE-3-CARBOXYLIC ACID HYDRAZIDE.
Used in Drug Development as a Potential Therapeutic Agent:
5-METHYL-1H-INDAZOLE-3-CARBOXYLIC ACID HYDRAZIDE has the potential to exhibit interesting pharmacological activities, making it a promising candidate for drug development. Its exploration in this area could lead to the discovery of new treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1203-96-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,2,0 and 3 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1203-96:
(6*1)+(5*2)+(4*0)+(3*3)+(2*9)+(1*6)=49
49 % 10 = 9
So 1203-96-9 is a valid CAS Registry Number.
1203-96-9Relevant academic research and scientific papers
HETEROARYL-SUBSTITUTED TRIAZOLES AS APJ RECEPTOR AGONISTS
-
Paragraph 0756; 0757, (2018/06/12)
Compounds of Formula (I) and Formula (II), pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.
